Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review
- PMID: 35016619
- PMCID: PMC8753832
- DOI: 10.1186/s12877-021-02721-w
Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is represented as the most common liver disease worldwide. NAFLD is associated with metabolic risk factors underpinned by insulin resistance, inflammation and endothelial dysfunction, leading to extrahepatic changes in central nervous diseases such as cognitive impairment, Alzheimer's disease and dementia. The aim of the review is to explore the association between NAFLD and cognitive function.
Methods: Using the PRISMA guidelines, a systematic electronic literature search was conducted in four databases: MEDLINE, PsychINFO, Embase and CINAHL from inception until March 2021. Neuropsychological tests utilised within each study were grouped into relevant cognitive domains including 'general cognition', 'reasoning', 'mental speed, attention and psychomotor speed', 'memory and learning', 'language', 'visuospatial perception' and 'ideas, abstraction, figural creations and mental flexibility'.
Results: Eleven observational studies that involved 7978 participants with a mean age of 51 years were included. Those with NAFLD had poor cognitive performance in three cognitive domains, including 'general cognition', 'mental speed, attention and psychomotor speed', and 'ideas, abstraction, figural creations and mental flexibility'.
Conclusion: The observed results from the 11 included studies showed that NAFLD was associated with lower cognitive performance across several domains. However, studies conducted to date are limited to observational designs and are heterogeneous with varying diagnostic tools used to assess cognitive function.
Trial registration: PROSPERO Registration: CRD42020161640 .
Keywords: Cirrhosis; Cognition; Cognitive function; Cognitive impairment; NAFLD; NASH.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.Liver Int. 2019 Sep;39(9):1713-1721. doi: 10.1111/liv.14161. Epub 2019 Jun 26. Liver Int. 2019. PMID: 31155826 Free PMC article.
-
Cognitive assessment of patients with nonalcoholic fatty liver disease.Eur J Gastroenterol Hepatol. 2018 Aug;30(8):944-950. doi: 10.1097/MEG.0000000000001131. Eur J Gastroenterol Hepatol. 2018. PMID: 29608442
-
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study.Cardiovasc Diabetol. 2018 Feb 16;17(1):28. doi: 10.1186/s12933-018-0670-7. Cardiovasc Diabetol. 2018. PMID: 29452601 Free PMC article.
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.World J Gastroenterol. 2014 Jul 7;20(25):8102-9. doi: 10.3748/wjg.v20.i25.8102. World J Gastroenterol. 2014. PMID: 25009382 Free PMC article. Review.
Cited by
-
Association of Metabolic Dysfunction-Associated Fatty Liver Disease with Cognitive Impairment and All-Cause Dementia: A Comprehensive Review.Turk J Gastroenterol. 2024 Feb;35(2):76-82. doi: 10.5152/tjg.2024.23629. Turk J Gastroenterol. 2024. PMID: 38454238 Free PMC article. Review.
-
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions.World J Hepatol. 2024 Jan 27;16(1):17-32. doi: 10.4254/wjh.v16.i1.17. World J Hepatol. 2024. PMID: 38313244 Free PMC article. Review.
-
From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function.Med Sci Monit. 2024 Jan 29;30:e943417. doi: 10.12659/MSM.943417. Med Sci Monit. 2024. PMID: 38282346 Free PMC article. Review.
-
Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease.BMJ Neurol Open. 2024 Jan 23;6(1):e000543. doi: 10.1136/bmjno-2023-000543. eCollection 2024. BMJ Neurol Open. 2024. PMID: 38268753 Free PMC article.
-
Late-Life Metabolic Dysfunction-Associated Steatotic Liver Disease and its Association With Physical Disability and Dementia.J Gerontol A Biol Sci Med Sci. 2024 Apr 1;79(4):glae011. doi: 10.1093/gerona/glae011. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38227760 Free PMC article.
References
-
- Kim D, Cholankeril G, Loomba R, Ahmed A. Prevalence of fatty liver disease and fibrosis detected by fibroscan in adults in the United States, 2017-2018. Clin Gastroenterol Hepatol. 2020;19(7):1499–501.
-
- GESA. Economic cost and health burden of liver disease in Australia: Gastroenterological Society of Australia. 2013. Available from: https://www.gesa.org.au/resources/economic-cost-and-health-burden-of-liv....
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
